*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

Zytiga 250mg Tablets

Abiraterone Acetate
250 mg
Tablet

ROA

Oral

Applicant Name

J & J Company West Africa Limited

NRN

B4-8220

Status

Active


ATC Code

L02BX0  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 X 120  

Product Description

95 RNW-PP-306499 Zytiga 250mg Tablets ABIRATERONE ACETATE Each tablet contains 250 mg abiraterone acetate, other ingredients inlcude microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone (K29/K32), colloidal anhydrous silica, and sodium laurilsulfate (see section 2, “ZYTIGA contains lactose and sodium”). B4-8220 Drugs ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS Imported Products 120*1 POM 2 1/10/2023 J & J COMPANY WEST AFRICA LIMITED, SINARI DARANIJO STREET, VICTORIA ISLAND LAGOS LAGOS 9062881239 DL-CONZACTCTRegulatoryAffairs@JNJZA.JNJ.com PATHEON INC., 2100 SYNTEX COURT, MISSISSAUGA, ONTARIO, CANADA, L5N 7K9, Canada

Manufacturer Name

Patheon Inc.

Manufacturer Country

CANADA  

Approval Date

2023-03-28  

Expiry Date

2028-03-27